Cytiva News
-
Cytiva Expanding US Operations
7/13/2022
The new chromatography resins manufacturing site is part of Cytiva and Pall Corporation’s 1.5 billion USD capacity expansion investment.
-
Cytiva Attains Business Continuity Management System ISO Certification
1/11/2022
The new ISO 22301:2019 certification covers methods and procedures for maintaining emergency response, crisis management, and business continuity capabilities, including communication, implementation, and continual improvement.
-
Cytiva Acquires GoSilico To Strengthen Digital Capabilities In Bioprocessing
6/2/2021
Global life sciences leader Cytiva has acquired the German scientific software maker GoSilico, in a move that will differentiate Cytiva as a premier partner in bioprocessing.
-
Cytiva's Fibro PrismA Technology Accelerates mAb Purification In LifeArc's Covid-19 Research
10/8/2020
Cytiva, a global life sciences leader, made Fibro PrismA, the first product based on its new protein A fiber chromatography technology, available commercially earlier this year. The new technology is already accelerating research for customers and collaborators, such as LifeArc.
-
GE Healthcare Launches Super-Resolution Microscope
9/23/2019
GE Healthcare launches a new microscope to support researchers and their ever-increasing need to see extreme details in cells, without having to choose whether speed, depth or clarity is more important. The DeltaVision OMX Flex super-resolution microscope is a highly stable, multichannel imaging platform optimized for structured illumination microscopy (SIM), and now includes EDGE confocal technology.
-
CBMG Accelerates Cell Therapy Manufacturing With GE Healthcare's New Start-To-Finish Solution
1/18/2018
Cellular Biomedicine Group Inc. (CBMG or the Company), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer, has announced its plan to configure part of its facility in Shanghai with GE Healthcare’s FlexFactory™ platform, which will be designed to speed up manufacturing timelines for its cell therapy clinical trials and commercial launch.
-
RiboBio And GE Healthcare Enter Into A Strategic Partnership For Oligonucleotide Drug Development And Manufacturing
11/21/2017
At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ("RiboBio") and GE Healthcare Life Sciences ("GE") held a strategic partnership signing ceremony
-
GE Healthcare Launches New Modular Chromatography System For Protein Purification
9/5/2012
GE Healthcare launches the of ÄKTA™ pure, a chromatography system for flexible, reliable and intuitive purification of proteins with the flexibility to support both routine and challenging purification requirements, as well as being adaptable to changing research needs.
-
GE Healthcare Launches Ni Sepharose Excel Chromatography Media For Direct Purification Of Histidine-Tagged Proteins Secreted From Eukaryotic Expression Systems
8/21/2012
GE Healthcare’s Ni Sepharose excel is an immobilized metal ion affinity chromatography (IMAC) medium (resin) for the direct capture and purification of secreted histidine-tagged recombinant proteins from eukaryotic cell culture supernatants.
-
GE Healthcare Launches FF High Performance Nitrocellulose Membranes Optimized For Diagnostic Assay Reproducibility
8/1/2012
GE Healthcare Life Sciences’ new Whatman FF High Performance (HP) membrane provides the industry with a new diagnostic membrane to enable fast, razor-sharp line separation and highly reproducible results for the detection of target molecules in liquids such as water, urine, blood and saliva.